Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.21 Million CAD | -56.56% |
| 2022 | 11.99 Million CAD | 3.82% |
| 2021 | 11.55 Million CAD | 41.55% |
| 2020 | 8.16 Million CAD | 103.77% |
| 2019 | 4 Million CAD | -42.58% |
| 2018 | 6.97 Million CAD | 100.89% |
| 2017 | 3.47 Million CAD | -51.08% |
| 2016 | 7.1 Million CAD | -16.07% |
| 2015 | 8.45 Million CAD | -28.69% |
| 2014 | 11.86 Million CAD | 25.68% |
| 2013 | 9.43 Million CAD | -25.01% |
| 2012 | 12.58 Million CAD | -39.05% |
| 2011 | 20.65 Million CAD | 19.4% |
| 2010 | 17.29 Million CAD | 243.7% |
| 2009 | 5.03 Million CAD | -28.98% |
| 2008 | 7.08 Million CAD | -11.22% |
| 2007 | 7.98 Million CAD | -14.52% |
| 2006 | 9.33 Million CAD | -40.08% |
| 2005 | 15.58 Million CAD | -20.94% |
| 2004 | 19.7 Million CAD | 40.34% |
| 2003 | 14.04 Million CAD | -22.3% |
| 2002 | 18.07 Million CAD | 34.38% |
| 2001 | 13.44 Million CAD | -16.99% |
| 2000 | 16.2 Million CAD | -27.35% |
| 1999 | 22.3 Million CAD | -26.4% |
| 1998 | 30.3 Million CAD | -28.71% |
| 1997 | 42.5 Million CAD | 38.89% |
| 1996 | 30.6 Million CAD | -25.18% |
| 1995 | 40.9 Million CAD | 143.45% |
| 1994 | 16.8 Million CAD | 273.33% |
| 1993 | 4.5 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.89 Million CAD | -6.08% |
| 2024 Q2 | 10.07 Million CAD | 105.86% |
| 2023 Q3 | 8.71 Million CAD | 37.67% |
| 2023 Q2 | 6.33 Million CAD | -29.33% |
| 2023 Q4 | 5.21 Million CAD | -40.21% |
| 2023 FY | 5.21 Million CAD | -56.56% |
| 2023 Q1 | 8.95 Million CAD | -25.33% |
| 2022 Q4 | 11.99 Million CAD | 214.94% |
| 2022 Q1 | 9.63 Million CAD | -16.62% |
| 2022 Q2 | 6.25 Million CAD | -35.07% |
| 2022 Q3 | 3.8 Million CAD | -39.11% |
| 2022 FY | 11.99 Million CAD | 3.82% |
| 2021 Q4 | 11.55 Million CAD | -17.51% |
| 2021 Q1 | 8.38 Million CAD | 2.77% |
| 2021 Q2 | 7.05 Million CAD | -15.93% |
| 2021 Q3 | 14 Million CAD | 98.6% |
| 2021 FY | 11.55 Million CAD | 41.55% |
| 2020 Q2 | 12.82 Million CAD | 19.56% |
| 2020 Q3 | 10 Million CAD | -22.01% |
| 2020 FY | 8.16 Million CAD | 103.77% |
| 2020 Q1 | 10.72 Million CAD | 167.75% |
| 2020 Q4 | 8.16 Million CAD | -18.38% |
| 2019 Q1 | 6.97 Million CAD | -0.03% |
| 2019 Q3 | 5.17 Million CAD | -16.17% |
| 2019 Q4 | 4 Million CAD | -22.57% |
| 2019 FY | 4 Million CAD | -42.58% |
| 2019 Q2 | 6.17 Million CAD | -11.51% |
| 2018 FY | 6.97 Million CAD | 100.89% |
| 2018 Q2 | 7.22 Million CAD | 116.37% |
| 2018 Q3 | 6.42 Million CAD | -11.15% |
| 2018 Q1 | 3.34 Million CAD | -3.8% |
| 2018 Q4 | 6.97 Million CAD | 8.63% |
| 2017 Q4 | 3.47 Million CAD | -18.93% |
| 2017 FY | 3.47 Million CAD | -51.08% |
| 2017 Q3 | 4.28 Million CAD | -19.72% |
| 2017 Q2 | 5.33 Million CAD | -11.93% |
| 2017 Q1 | 6.05 Million CAD | -14.66% |
| 2016 FY | 7.1 Million CAD | -16.07% |
| 2016 Q2 | 12.55 Million CAD | -18.78% |
| 2016 Q4 | 7.1 Million CAD | -24.27% |
| 2016 Q3 | 9.37 Million CAD | -25.34% |
| 2016 Q1 | 15.46 Million CAD | 82.78% |
| 2015 Q4 | 8.45 Million CAD | -19.96% |
| 2015 FY | 8.45 Million CAD | -28.69% |
| 2015 Q3 | 10.56 Million CAD | -20.43% |
| 2015 Q2 | 13.28 Million CAD | 45.24% |
| 2015 Q1 | 9.14 Million CAD | -22.91% |
| 2014 Q3 | 13.78 Million CAD | 278.2% |
| 2014 Q4 | 11.86 Million CAD | -13.97% |
| 2014 FY | 11.86 Million CAD | 25.68% |
| 2014 Q1 | 5.9 Million CAD | -37.39% |
| 2014 Q2 | 3.64 Million CAD | -38.3% |
| 2013 FY | 9.43 Million CAD | -25.01% |
| 2013 Q3 | 11.25 Million CAD | -13.4% |
| 2013 Q4 | 9.43 Million CAD | -16.12% |
| 2013 Q2 | 12.99 Million CAD | 25.9% |
| 2013 Q1 | 10.32 Million CAD | -18.0% |
| 2012 FY | 12.58 Million CAD | -39.05% |
| 2012 Q4 | 12.58 Million CAD | -11.03% |
| 2012 Q2 | 16.39 Million CAD | -11.29% |
| 2012 Q3 | 14.14 Million CAD | -13.74% |
| 2012 Q1 | 18.48 Million CAD | -10.48% |
| 2011 Q3 | 22.09 Million CAD | 55.91% |
| 2011 Q4 | 20.65 Million CAD | -6.52% |
| 2011 Q1 | 15.49 Million CAD | -10.39% |
| 2011 FY | 20.65 Million CAD | 19.4% |
| 2011 Q2 | 14.16 Million CAD | -8.58% |
| 2010 Q1 | 21.28 Million CAD | 322.93% |
| 2010 FY | 17.29 Million CAD | 243.7% |
| 2010 Q4 | 17.29 Million CAD | -7.37% |
| 2010 Q2 | 19.83 Million CAD | -6.79% |
| 2010 Q3 | 18.67 Million CAD | -5.88% |
| 2009 Q4 | 5.03 Million CAD | -5.8% |
| 2009 Q3 | 5.34 Million CAD | -9.18% |
| 2009 FY | 5.03 Million CAD | -28.98% |
| 2009 Q2 | 5.88 Million CAD | -14.21% |
| 2009 Q1 | 6.85 Million CAD | -3.23% |
| 2008 Q3 | 6.93 Million CAD | -6.58% |
| 2008 Q4 | 7.08 Million CAD | 2.24% |
| 2008 FY | 7.08 Million CAD | -11.22% |
| 2008 Q2 | 7.41 Million CAD | -1.94% |
| 2008 Q1 | 7.56 Million CAD | -5.2% |
| 2007 Q2 | 8.7 Million CAD | -4.24% |
| 2007 Q4 | 7.98 Million CAD | -8.0% |
| 2007 Q1 | 9.09 Million CAD | 0.0% |
| 2007 FY | 7.98 Million CAD | -14.52% |
| 2007 Q3 | 8.67 Million CAD | -0.4% |
| 2006 FY | 9.33 Million CAD | -40.08% |
| 2006 Q3 | 9.68 Million CAD | -5.54% |
| 2006 Q2 | 10.25 Million CAD | -11.32% |
| 2006 Q1 | 11.55 Million CAD | 1.68% |
| 2005 FY | 15.58 Million CAD | -20.94% |
| 2005 Q4 | 11.36 Million CAD | -10.11% |
| 2005 Q1 | 15.58 Million CAD | -10.29% |
| 2005 Q2 | 13.93 Million CAD | -10.56% |
| 2005 Q3 | 12.64 Million CAD | -9.25% |
| 2004 Q3 | 16.3 Million CAD | -10.77% |
| 2004 Q2 | 18.26 Million CAD | -7.3% |
| 2004 Q4 | 17.36 Million CAD | 6.55% |
| 2004 FY | 19.7 Million CAD | 40.34% |
| 2004 Q1 | 19.7 Million CAD | -4.73% |
| 2003 Q1 | 14.04 Million CAD | -17.38% |
| 2003 FY | 14.04 Million CAD | -22.3% |
| 2003 Q4 | 20.68 Million CAD | 43.51% |
| 2003 Q3 | 14.41 Million CAD | 17.43% |
| 2003 Q2 | 12.27 Million CAD | -12.58% |
| 2002 Q4 | 16.99 Million CAD | -3.06% |
| 2002 Q2 | 15.86 Million CAD | -12.21% |
| 2002 Q1 | 18.07 Million CAD | -13.72% |
| 2002 FY | 18.07 Million CAD | 34.38% |
| 2002 Q3 | 17.53 Million CAD | 10.51% |
| 2001 Q2 | 19.96 Million CAD | 48.42% |
| 2001 Q1 | 13.44 Million CAD | -4.12% |
| 2001 Q3 | 22.03 Million CAD | 10.4% |
| 2001 Q4 | 20.94 Million CAD | -4.95% |
| 2001 FY | 13.44 Million CAD | -16.99% |
| 2000 Q3 | 14.99 Million CAD | -7.46% |
| 2000 FY | 16.2 Million CAD | -27.35% |
| 2000 Q2 | 16.2 Million CAD | 0.0% |
| 2000 Q4 | 14.02 Million CAD | -6.44% |
| 2000 Q1 | 16.2 Million CAD | 0.62% |
| 1999 Q1 | 22.3 Million CAD | -8.61% |
| 1999 Q4 | 16.1 Million CAD | -6.94% |
| 1999 FY | 22.3 Million CAD | -26.4% |
| 1999 Q3 | 17.3 Million CAD | -14.36% |
| 1999 Q2 | 20.2 Million CAD | -9.42% |
| 1998 Q3 | 27.9 Million CAD | -0.36% |
| 1998 Q2 | 28 Million CAD | -7.59% |
| 1998 FY | 30.3 Million CAD | -28.71% |
| 1998 Q4 | 24.4 Million CAD | -12.54% |
| 1998 Q1 | 30.3 Million CAD | -9.01% |
| 1997 Q3 | 35.9 Million CAD | -8.18% |
| 1997 Q4 | 33.3 Million CAD | -7.24% |
| 1997 Q1 | 42.5 Million CAD | 33.65% |
| 1997 FY | 42.5 Million CAD | 38.89% |
| 1997 Q2 | 39.1 Million CAD | -8.0% |
| 1996 Q2 | 38.1 Million CAD | 24.51% |
| 1996 Q3 | 35.3 Million CAD | -7.35% |
| 1996 FY | 30.6 Million CAD | -25.18% |
| 1996 Q1 | 30.6 Million CAD | -7.55% |
| 1996 Q4 | 31.8 Million CAD | -9.92% |
| 1995 Q2 | 38.6 Million CAD | -5.62% |
| 1995 Q4 | 33.1 Million CAD | -9.07% |
| 1995 FY | 40.9 Million CAD | 143.45% |
| 1995 Q1 | 40.9 Million CAD | -4.44% |
| 1995 Q3 | 36.4 Million CAD | -5.7% |
| 1994 Q2 | 45.6 Million CAD | 171.43% |
| 1994 Q1 | 16.8 Million CAD | 0.0% |
| 1994 FY | 16.8 Million CAD | 273.33% |
| 1994 Q4 | 42.8 Million CAD | -3.6% |
| 1994 Q3 | 44.4 Million CAD | -2.63% |
| 1993 FY | 4.5 Million CAD | 0.0% |
| 1993 Q1 | 4.5 Million CAD | -9.65% |
| 1992 Q4 | 4.98 Million CAD | -24.69% |
| 1992 Q2 | 1.07 Million CAD | 0.0% |
| 1992 Q3 | 6.61 Million CAD | 514.32% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -310.638% |
| Arrayit Corporation | 1 Million USD | -420.897% |
| Atlantic International Corp. | 4.43 Million USD | -17.461% |
| Biocept, Inc. | 30.87 Million USD | 83.121% |
| Bioqual, Inc. | 56.58 Million USD | 90.791% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -2146.779% |
| DermTech, Inc. | 121.93 Million USD | 95.726% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.875% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 70.688% |
| iMD Companies, Inc. | 190.13 Thousand USD | -2640.655% |
| IDenta Corp. | 1.52 Million USD | -240.75% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 59.98% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 36.851% |
| InVitro International | 1.53 Million USD | -239.699% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 80.584% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -225289.273% |
| Medical Imaging Corp. | 4.19 Million USD | -24.319% |
| NovelStem International Corp. | 2.25 Million USD | -131.133% |
| Optigenex Inc. | 1.88 Million USD | -175.964% |
| PharmChem, Inc. | 2.76 Million USD | -88.425% |
| Proteome Sciences plc | 14.58 Million USD | 64.274% |
| Response Genetics, Inc | 48.88 Million USD | 89.34% |
| Rennova Health, Inc. | 20.57 Million USD | 74.67% |
| RushNet, Inc. | 6.04 Million USD | 13.834% |
| ScreenPro Security Inc. | 1.26 Million USD | -313.126% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -1003.037% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -643.736% |
| Todos Medical Ltd. | 15.26 Million USD | 65.868% |